Current projects
- stimulation and inhibition of asthmatic and non-asthmatic airway smooth muscle cell proliferation
- airway wall remodelling - mechanisms and effect of therapeutic interventions
- b-agonist and corticosteroid interactions on human airway smooth muscle function
- human airway smooth muscle cell production of extracellular matrix / matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases and integrins
- flow cytometry of adhesion molecules on human airway smooth muscle and inflammatory cells
- effect of respiratory viruses on cellular function
- role of angiogenesis in airway remodelling
- intracellular calcium signalling in contraction, relaxation and proliferation
- mast cell mediators and airway smooth muscle functions
- effect of cytokines on human airway smooth muscle
- airway smooth muscle production of mast cell chemotaxins
- production of cytokines by human T-lymphocytes
- production of cytokines by human airway smooth muscle cells
- mechanisms of action of sphingosine 1-phosphate, a new inflammatory mediator in asthma
- effect of b-agonists on cytokine gene expression in human airway smooth muscle cells
- inflammatory and smooth muscle cell interactions
- morphometry of airway wall structure
- the role of extracellular matrix remodelling, by matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs), in the progression of malignant mesothelioma and fibrotic lung diseases
- examination of the proliferative profile of fibroblasts obtained from various fibroproliferative disease of the lung eg lung fibrosis, chronic obstructive pulmonary disease (COPD), and emphysema.
- measurement of plasma concentrations of inhaled corticosteroids in human volunteers
- in vitro assessment of steroid effects on potential target cells such as osteocytes and skin fibroblasts
- models of steroid potency on cytokine release
- optimisation of asthma management through pharmacist intervention
- the role of the pharmacist in asthma management
- the quality use of respiratory medication
- respiratory device technique
- nebulizer and metered-dose inhaler use for b agonists
- patient choice in drug therapy - pharmacoeconomic analysis
- models of best practice in Clinical Pharmacy